Abivax S.A.

ABVX.PA · PAR
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-€100,784-€94,604-€81,638-€95,787
Dep. & Amort.€524€524€576€377
Deferred Tax€0€0€0€1,098
Stock-Based Comp.€11,021€0€11,421€8,123
Change in WC€2,287€14,468€4,023€12,046
Other Non-Cash€20,334€9,273-€19,557€25,570
Operating Cash Flow-€66,618-€70,339-€85,175-€69,531
Investing Activities
PP&E Inv.-€63-€404-€239-€117
Net Acquisitions€0€0€0€0
Inv. Purchases€0-€359-€232-€9,351
Inv. Sales/Matur.€0€0€0€684
Other Inv. Act.€1,332-€232€13,929€1
Investing Cash Flow€1,269-€995€13,458-€8,783
Financing Activities
Debt Repay.-€13,036-€4,975€42,587€0
Stock Issued€0€435€0€202,015
Stock Repurch.€0€0-€1€0
Dividends Paid€0€0€0€0
Other Fin. Act.€4,269-€2,834-€2,264€218,548
Financing Cash Flow-€8,767-€7,374€40,322€218,548
Forex Effect-€1,785€612€1,770-€5,072
Net Chg. in Cash-€42,630-€78,096-€29,625€137,561
Supplemental Information
Beg. Cash€103,576€222,317€251,942€114,381
End Cash€60,946€144,221€222,317€251,942
Free Cash Flow-€66,681-€70,743-€85,411-€69,648